ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,560, issued on Sept. 23, was assigned to Procomcure Biotech GmbH (Thalgau, Austria).
"Assays for the detection of SARS-CoV-2 mutants" was invented by Kamil Onder (Seekirchen am Wallersee, Austria) and Sven Breunig (Seekirchen am Wallersee, Austria).
According to the abstract* released by the U.S. Patent & Trademark Office: "An oligonucleotide, having a 5' terminus and a 3' terminus, wherein said oligonucleotide is detectably labeled and has a nucleotide sequence that consists essentially of one of the nucleotide sequences selected from SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:29, SEQ ID NO:30, SEQ ID ...